Along with Roche Pharmaceuticals, Roche Diagnostics is an important part of the foundation that modern healthcare builds upon.
Our broad range of innovative diagnostic tests and systems play a pivotal role in the groundbreaking area of integrated healthcare solutions and cover the early detection, targeted screening, evaluation and monitoring of disease.
Roche Diagnostics is active in all market segments, from scientific research and clinical laboratory systems to patient self-monitoring.
The Roche Diagnostics product portfolio at a glance:
- blood glucose meters for people with diabetes
- point-of-care testing devices for use in doctors’ offices
- high-throughput analysers for hospitals and commercial diagnostic laboratories
- state-of-the-art instruments and reagents for life science research
Roche Professional Diagnostics
Roche Professional Diagnostics’ products support clinical decision making in a wide variety of indication fields, including oncology, virology, cardiovascular, inflammatory and infectious diseases.
Roche Professional Diagnostics provides integrated cobas® branded solutions for blood serum testing in commercial and hospital labs, medical centers and laboratory networks. Further cobas®, CoaguChek® and Accu-Chek® products are designed for the professional point-of-care market and utilize parameters such as cardiac markers, blood glucose and blood gases in the emergency room or in the intensive care unit. CoaguChek® products also allow patients to self-test their coagulation status at home.
By including other diagnostic disciplines such as hematology and urinalysis, RPD provides a true continuum of In-Vitro Diagnostics, offering healthcare professionals actionable information of the right type at the right time and place.
Roche Diabetes Care
Roche Diabetes Care’s products are all designed with the same basic aims in mind: to help people with diabetes live healthy, productive lives and to make managing diabetes easier. Monitoring systems with integrated lancets and test strips and software for storing and analysing data are an increasingly important part of Roche’s diabetes care portfolio because they improve glycemic (blood glucose) control for many users, in addition to offering greater convenience. Activities aimed at integrating glucose monitoring and data management with insulin delivery are ongoing and may one day result in systems that closely mimic the way the healthy pancreas regulates blood glucose levels.
Roche Molecular Diagnostics
Roche Molecular Diagnostics develops and manufactures innovative tests based on the Nobel Prize winning polymerase chain reaction (PCR) technology. PCR technology underlies a new generation of medical diagnostic tests that allow healthcare providers to select and monitor patient response to therapy or identify molecular characteristics of a disease. Roche Molecular Diagnostics’ blood-screening systems also help to ensure the safety of blood and blood products before they are used for medical procedures.
With its broad product portfolio of oncology, virology, microbiology and blood-screening tests, customers include researchers, physicians, patients, hospitals and laboratories worldwide.
Roche Applied Science
Roche Applied Science supplies a broad and growing range of instruments and highly specific reagents and test kits for use in the life science research market and for industrial applications. Its product portfolio and capabilities are especially strong in genomics and cellomics, sciences that are crucial for our understanding and the treatment of disease.
Roche Tissue Diagnostics
Ventana Medical Systems Inc., a member of the Roche group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s “Smart Systems” – intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals.
Together with Roche, Ventana is driving personalised medicine through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies.